The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Carisma Therapeutics, Inc.(NASDAQ:CARM) 
Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. Its solutions are used to play a crucial role in the innate and adaptive immune response, and technology leverages advances in macrophage biology, chimeri...
Website: https://carismatx.com
Founded: 2016
Full Time Employees: 92
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Carisma Therapeutics . Days Payable Outstanding ttm (DPO)
Carisma Therapeutics . Days Receivable Outstanding ttm (DSO)
Carisma Therapeutics . Op Cashflow Per Share ttm
Carisma Therapeutics . Free Cashflow Per Share ttm
Carisma Therapeutics . Cash Per Share ttm
Carisma Therapeutics . P/S ratio ttm
Carisma Therapeutics . (GAAP) P/E ratio ttm
Carisma Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.